Biotechnology is a rapidly advancing industry, with new startups emerging across the globe. Beijing, China, a major technology hub in Asia, is home to several new biotech startups, many of which were founded in 2020 or later. These startups are driving innovation and disrupting the biotech industry in fresh and interesting ways. Whether they’re developing breakthroughs in pharmaceuticals or pioneering new methods of manufacturing, these startups are certainly ones to watch.
In this article, we will highlight some of the most promising and innovative biotechnology startups in Beijing. From businesses devoted to developing antibody drugs for the treatment of infectious diseases and cancers, to those generating therapies for kidney diseases, these startups represent the cutting edge of the biotech industry in Asia. They are shaping the future of biotechnology and have the potential to make significant contributions to healthcare and manufacturing industries globally.
So, without further ado, let’s take a closer look at these startups and learn more about their work, their products and their mission to drive progress in the biotech industry.
Singlomics is focused on using single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers. Co-founded by Xiaoliang Sunney Xie and Yunlong Cao, this startup is dedicated to healthcare improvement and aims to transform the way diseases are diagnosed and treated.
SanReno Therapeutics was formed as a joint venture of Chinook Therapeutics, Frazier Healthcare Partners and Pivotal bioVenture Partners China. The company’s mission is to develop, manufacture and commercialize kidney disease therapies in the People’s Republic of China, Hong Kong, Macau, Taiwan and Singapore.
Toll Biotech is a drug research and development company that focuses on the development of a series of small molecules for Toll-like receptor (TLR) targets. This company, established in April 2020, was initiated by the team of Professor Yin Hang from the School of Pharmacy at Tsinghua University.
Based in Beijing, Zeno Biotech operates in the sectors of biotechnology, manufacturing, and product research. However, additional information about the company’s focus and operations is currently unavailable.
Weiyuan Synthetic Biotechnology
Weiyuan Synthetic Biotechnology is another startup working in the field of biotechnology, with a focus on the food and beverage and manufacturing sectors. Unfortunately, there isn’t more specific information available about this startup at present.
Founded by Professor Guoqiang Chen in 2021, PhaBuilder is a platform-based & product-based company with advanced technology in synthetic biology. They’re involved in the transformation and engineering application of halophilic microbes. They’re currently developing a range of high-value-added products and already have two PHA plants under construction. PhaBuilder aims to build 3-5 large-scale production bases throughout China within five years and has raised around 300 million yuan in two rounds of financing.
Helixon is a biotechnology company that commits to improving the speed and efficiency of new drug development. They have developed an AI drug development platform and an antibody engineering experiment platform to provide researchers with intelligent systems for molecular calculation, simulation, and design.
Life Biosciences is a startup that provides animal behaviour analysis services. Some of their offerings include blood biochemistry, routine blood testing, pathological staining, immunohistochemistry, fluorescence, molecular experiments, cell experiments, flow cytometry, x-ray irradiation, and nuclear magnetic resonance.
Green Nitrogen operates in the AgTech, Biotechnology, and Farming sectors. At the moment, specific information about the company’s exact focus and operations is not available.